Skip to content

NACDS grant partners increase visibility on adult vaccination

NACDS grant partners have published articles in the journal Vaccine outlining the results of projects designed to increase adult vaccination. The prevalence of vaccine-preventable diseases in adults remains a significant public health issue in the United States.

Table of Contents

ARLINGTON, Va. — NACDS grant partners have published articles in the journal Vaccine outlining the results of projects designed to increase adult vaccination. The prevalence of vaccine-preventable diseases in adults remains a significant public health issue in the United States. The demonstration projects were supported both by the Center for Disease Control and Prevention (CDC) and NACDS.

NACDS’ Washington State partner’s article shows that community pharmacists contribute to improving adult immunizations through vaccine “forecasting” and proactive recommendation. The Nebraska and Iowa partners’ article details the implementation of a technology platform aimed at increasing adult vaccination rates in community pharmacies.

In total, these three projects provided more than 300,000 adult immunizations. Over 300 participating pharmacies were connected to their state-based immunization registry, with 150 pharmacies newly connected as a result of the grant.

The accessibility of pharmacies has been an important and documented factor in increasing immunization rates over the past two decades, and NACDS has consistently advocated for pharmacists to provide vaccinations. As highly trusted healthcare providers, pharmacists have the legal authority to administer immunizations in all 50 states.

The demonstration projects were supported by Grant Federal Award Identification Number, IH23IP000985, for $800,000 funded by the CDC. NACDS contributed an additional $300,000. Their respective content is solely the responsibility of the grantees and does not necessarily represent the official views of the CDC or the U.S. Department of Health and Human Services.

Comments

Latest